Kishen Chahwala
Business Development Manager @Enhanced Genomics
Signup · Get unlimited contacts
WORK HISTORY
Business Development Manager @Enhanced Genomics
Cambridge, GB
Leading BD at Enhanced Genomics, a pre-commercial multi-omics platform company focused on the non-coding genome and cell type-specific target identification. Responsible for the full BD cycle across pharma and investor audiences, from opportunity scouting and scientific due diligence through to deal execution.•Secured a platform collaboration with a top-ten pharmaceutical company through targeted outreach, scientific evaluation, and relationship management, achieving a critical milestone for the company\'s next funding round.•Directed screening and technical assessment of inbound and outbound opportunities, evaluating scientific rationale, clinical and commercial fit, and strategic alignment, delivering recommendations directly to leadership.•Built a senior-level network of nearly 200 pharma, biotech, and investor contacts through targeted outreach and partnering forums including JP Morgan Healthcare Conference and BIO-Europe.•Proactively scouted and monitored the external landscape for emerging technologies and programmes of strategic relevance, synthesising findings to inform BD strategy and internal prioritisation.•Spearheaded a cross-functional disease indication prioritisation exercise with scientific teams, assessing platform fit and commercial potential to directly shape development strategy.•Collaborated with leadership to develop company narrative and support the strategic pivot from service platform to therapeutics company.
EDUCATION
The Perse School, Cambridge
Secondary Education
University of Leicester
Bachelor of Science - BSc, Neuroscience
University of Cambridge
Doctor of Philosophy - PhD, Neuroscience and Genetics
ABOUT KISHEN CHAHWALA
Business development leader with a PhD in Genetics from the University of Cambridge and a track record of driving partnerships and licensing in pharma and biotech.I currently lead BD at Enhanced Genomics, a pre-commercial genomics and multi-omics platform company focused on the non-coding genome and cell type-specific target identification. My work spans the full BD cycle: scouting and evaluating external opportunities, conducting scientific and technical due diligence, building and managing senior stakeholder relationships, and advancing deals from early discussions through to execution.My scientific background in genetics and neuroscience means I can engage credibly with R&D teams, assess pipeline assets with genuine depth, and translate complex data into clear commercial narratives for pharma and investor audiences.Key areas of focus:Search & evaluation and technical due diligenceLicensing and strategic partnershipsGenomics, multi-omics, and CNS biologyMarket and competitive analysisStakeholder engagement across pharma, biotech, and investors
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.